Does Dr. CHARLES HULTMAN have financial conflicts of interest?

Dr. CHARLES HULTMAN (MD) has received a total of $69,800 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $69,800 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CHARLES HULTMAN?

According to CMS Open Payments data, Dr. CHARLES HULTMAN received funding from AVITA MEDICAL AMERICAS ($39,386), VERICEL CORPORATION ($24,521), and KERECIS LIMITED ($1,016).

Does Dr. CHARLES HULTMAN receive research grants or speaking fees?

Dr. CHARLES HULTMAN has received $69,800 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. CHARLES HULTMAN

MDReal-Time Hydrated

Specialty: Surgery, Plastic and Reconstructive Surgery

Practice Location: RALEIGH, NC 27610

NPI Number: 1245324243

LIFETIME INDUSTRY VALUE

$69,800

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. HULTMAN is a verified Surgery, Plastic and Reconstructive Surgery practitioner based in RALEIGH, NC.

Between 2021 and 2025, Dr. HULTMAN had an overall industry promotional and research financial footprint of $69,800 as recorded in the federal CMS Open Payments database.

$69,800 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. HULTMAN's primary funding source is AVITA MEDICAL AMERICAS, which accounts for $39,386 (representing 56.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

AVITA MEDICAL AMERICAS

Rank 1

$39,386

56.4%

VERICEL CORPORATION

Rank 2

$24,521

35.1%

KERECIS LIMITED

Rank 3

$1,016

1.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.